Zoe Athanassa
Impact in
-
- Antibiotic Use and Resistance
-
- Nosocomial Infections in ICU
Papers in
-
- Antibiotic Resistance in Bacteria 5
-
- Nosocomial Infections in ICU 5
- Co-authors
- Matthew E. FalagasIlias Ι. SiemposGeorge DimοpoulosAlexandros GrammatikosVasileios KouranosDrosos E. KarageorgopoulosPetros KopteridesDimitrios K. Matthaiou
- Journals
- Drugs (3 papers)Canadian Medical Association Journal (1 paper)Life (1 paper)QJM (1 paper)Expert Review of Anti-infective Therapy (1 paper)
- Partner nations
- GreeceUnited StatesSweden
In The Last Decade
Zoe Athanassa
13 papers receiving 595 citations
Peers
Comparison fields: 5 of 68
- Applied Microbiology and Biotechnology 103
- Critical Care and Intensive Care Medicine 176
- Molecular Medicine 165
- Epidemiology 385
- Pharmacology 150
Countries citing papers authored by Zoe Athanassa
This map shows the geographic impact of Zoe Athanassa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zoe Athanassa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zoe Athanassa more than expected).
Fields of papers citing papers by Zoe Athanassa
This network shows the impact of papers produced by Zoe Athanassa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zoe Athanassa. The network helps show where Zoe Athanassa may publish in the future.
Co-authors
The 25 scholars most cited alongside Zoe Athanassa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2023 | 11 | |
| 4 | 2016 | 24 | |
| 5 | Concentration-related mydriasis in a patient with renal dysfunction treated with phenytoin. | 2016 | 2 |
| 6 | 2015 | 1 | |
| 7 | 2012 | 117 | |
| 8 | 2010 | 83 | |
| 9 | 2009 | 33 | |
| 10 | 2008 | 113 | |
| 11 | 2008 | 55 | |
| 12 | 2008 | 69 | |
| 13 | 2008 | 19 | |
| 14 | 2008 | 31 | |
| 15 | 2008 | 61 |
About Zoe Athanassa
Zoe Athanassa is a scholar working on Molecular Medicine, Critical Care and Intensive Care Medicine, Applied Microbiology and Biotechnology, Epidemiology and Pharmacology, having authored 15 papers that have together received 621 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (7 papers), Antibiotic Resistance in Bacteria (5 papers), Nosocomial Infections in ICU (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers), Muscle and Compartmental Disorders (1 paper), Neutropenia and Cancer Infections (1 paper) and Tuberculosis Research and Epidemiology (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (103 citations), Critical Care and Intensive Care Medicine (176 citations), Molecular Medicine (165 citations), Epidemiology (385 citations) and Pharmacology (150 citations). Zoe Athanassa has collaborated with scholars based in Greece, United States and Sweden. Frequent co-authors include Matthew E. Falagas, Ilias Ι. Siempos, George Dimοpoulos, Alexandros Grammatikos, Vasileios Kouranos, Drosos E. Karageorgopoulos, Petros Kopterides, Dimitrios K. Matthaiou, George Baltopoulos and Sophia L. Markantonis. Their work appears in journals such as Drugs, Canadian Medical Association Journal, Life, QJM and Expert Review of Anti-infective Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.